Atlas Trials

Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients

Clinical trial NCT00327249 · COMPLETED

Trial details

NCT number
NCT00327249
Sponsor
AmpliMed Corporation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2005-10-01
Primary completion
2006-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.